Pfizer likely to remove lid on drug price increases in January

Chairman and CEO Ian Read said Pfizer Inc. (NYSE:PFE) will likely end its agreement to defer drug price increases and return to "business as normal" by year end. Read's comments, which came during the pharma’s 3Q18 earnings conference call Tuesday, could suggest Pfizer does not expect

Read the full 464 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE